1. |
Li L, Zhang Y, Jia L, et al. Levetiracetam versus phenytoin for the treatment of established status epilepticus: a systematic review and meta-analysis of randomized controlled trials. Seizure, 2020, 78: 43-48.
|
2. |
晋琅, 刘永红. 成簇癫痫发作. 中华神经科杂志, 2021, 54(1): 55-59.
|
3. |
Pichler M, Hocker S. Management of status epilepticus. Handb Clin Neurol, 2017, 140: 131-151.
|
4. |
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr, 2016, 16(1): 48-61.
|
5. |
Brigo F, Bragazzi NL, Lattanzi S, et al. A critical appraisal of randomized controlled trials on intravenous phenytoin in convulsive status epilepticus. Eur J Neurol, 2018, 25(3): 451-463.
|
6. |
Silbergleit R, Elm JJ. Levetiracetam no better than phenytoin in children with convulsive status epilepticus. Lancet, 2019, 393(10186): 2101-2102.
|
7. |
杨俊超, 陈君颖, 许春艳, 等. 运动疗法治疗慢性腰痛效果的网状Meta分析. 中国循证医学杂志, 2021, 21(1): 28-39.
|
8. |
易跃雄, 张蔚, 刘小媛, 等. 网状Meta分析图形结果解读. 中国循证医学杂志, 2015, 15(1): 103-109.
|
9. |
Chamberlain JM, Kapur J, Shinnar S, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet, 2020, 395(10231): 1217-1224.
|
10. |
Nalisetty S, Kandasamy S, Sridharan B, et al. Clinical effectiveness of levetiracetam compared to fosphenytoin in the treatment of benzodiazepine refractory convulsive status epilepticus. Indian J Pediatr, 2020, 87(7): 512-519.
|
11. |
Handral A, Veerappa BG, Gowda VK, et al. Levetiracetam versus fosphenytoin in pediatric convulsive status epilepticus: a randomized controlled trial. J Pediatr Neurosci, 2020, 15(3): 252-256.
|
12. |
Nazir M, Tarray RA, Asimi R, et al. Comparative efficacy of IV phenytoin, IV valproate, and IV levetiracetam in childhood status epilepticus. J Epilepsy Res, 2020, 10(2): 69-73.
|
13. |
Vignesh V, Rameshkumar R, Mahadevan S. Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: a randomized double-blind controlled clinical trial. Indian Pediatr, 2020, 57(3): 222-227.
|
14. |
Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med, 2019, 381(22): 2103-2113.
|
15. |
Lyttle MD, Rainford NEA, Gamble C, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet, 2019, 393(10186): 2125-2134.
|
16. |
Dalziel SR, Borland ML, Furyk J, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet, 2019, 393(10186): 2135-2145.
|
17. |
Wani G, Imran A, Dhawan N, et al. Levetiracetam versus phenytoin in children with status epilepticus. J Family Med Prim Care, 2019, 8(10): 3367-3371.
|
18. |
Burman RJ, Ackermann S, Shapson-Coe A, et al. A comparison of parenteral phenobarbital vs. parenteral phenytoin as second-line management for pediatric convulsive status epilepticus in a resource-limited setting. Front Neurol, 2019, 10: 506.
|
19. |
Noureen N, Khan S, Khursheed A, et al. Clinical efficacy and safety of injectable levetiracetam versus phenytoin as second-line therapy in the management of generalized convulsive status epilepticus in children: an open-label randomized controlled trial. J Clin Neurol, 2019, 15(4): 468-472.
|
20. |
Nene D, Mundlamuri RC, Satishchandra P, et al. Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): a prospective randomized controlled pilot study. Seizure, 2019, 65: 111-117.
|
21. |
Senthilkumar C, Selvakumar P, Kowsik M. Randomized controlled trial of levetiracetam versus fosphenytoin for convulsive status epilepticus in children. Int J Pediatr Res, 2018, 5(4): 237-242.
|
22. |
Khajeh A, Yaghoubinia F, Yaghoubi S, et al. Comparison of the effect of phenobarbital versus sodium valproate in management of children with status epilepticus. Iran J Child Neurol, 2018, 12(4): 85-93.
|
23. |
Singh K, Aggarwal A, Faridi MMA, et al. IV levetiracetam versus IV phenytoin in childhood seizures: a randomized controlled trial. J Pediatr Neurosci, 2018, 13(2): 158-164.
|
24. |
Amiri-Nikpour MR, Nazarbaghi S, Eftekhari P, et al. Sodium valproate compared to phenytoin in treatment of status epilepticus. Brain Behav, 2018, 8(5): e00951.
|
25. |
Gujjar AR, Nandhagopal R, Jacob PC, et al. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: a prospective, randomized study. Seizure, 2017, 49: 8-12.
|
26. |
Su Y, Liu G, Tian F, et al. Phenobarbital versus valproate for generalized convulsive status epilepticus in adults: a prospective randomized controlled trial in China. CNS Drugs, 2016, 30(12): 1201-1207.
|
27. |
Mundlamuri RC, Sinha S, Subbakrishna DK, et al. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam-Pilot study. Epilepsy Res, 2015, 114: 52-58.
|
28. |
Chakravarthi S, Goyal MK, Modi M, et al. Levetiracetam versus phenytoin in management of status epilepticus. J Clin Neurosci, 2015, 22(6): 959-963.
|
29. |
Malamiri RA, Ghaempanah M, Khosroshahi N, et al. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur J Paediatr Neurol, 2012, 16(5): 536-541.
|
30. |
Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure, 2007, 16(6): 527-532.
|
31. |
Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology, 2006, 67(2): 340-342.
|
32. |
Nakamura K, Ohbe H, Matsui H, et al. Phenytoin versus fosphenytoin for second-line treatment of status epilepticus: propensity score matching analysis using a nationwide inpatient database. Seizure, 2020, 80: 124-130.
|
33. |
Brigo F, Del Giovane C, Nardone R, et al. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis. Epilepsy Behav, 2019, 101(PtB): 106466.
|
34. |
王绚, 张永, 张媛媛. 基于AERS的丙戊酸不良反应信号挖掘与数据分析. 中国医院药学杂志, 2020, 40(1): 71-77.
|
35. |
张天照. 左乙拉西坦和卡马西平治疗癫痫的临床研究. 中国临床药理学杂志, 2021, 37(8): 962-965.
|
36. |
Thibault C, Naim MY, Abend NS, et al. A retrospective comparison of phenobarbital and levetiracetam for the treatment of seizures following cardiac surgery in neonates. Epilepsia, 2020, 61(4): 627-635.
|
37. |
周静. 癫痫患者172例丙戊酸钠血药浓度分析. 临床合理用药杂志, 2021, 14(10): 147,149.
|
38. |
Arroyo S, Crawford P. Safety profile of levetiracetam. Epileptic Disord, 2003, 5(Suppl1): S57-S63.
|